Home / Biopharma / Stocks Hammered on Sluggish Data: Ariad Pharmaceuticals Inc. (NASDAQ:ARIA), Opko Health, Inc. (NASDAQ:OPK)

Stocks Hammered on Sluggish Data: Ariad Pharmaceuticals Inc. (NASDAQ:ARIA), Opko Health, Inc. (NASDAQ:OPK)

Following analysis criteria, Ariad Pharmaceuticals Inc. (NASDAQ:ARIA) attains noticeable attention, it are knocking down -0.73% to traded at $13.59. ARIA attains analyst recommendation of 2.20 on scale of 1-5 with week’s performance of -2.65%.

The firm has noticeable returns on equity ratio of 68.80%, which shows how much profit each dollar of ordinary stockholders’ equity generates. The returns on investment very popular metric among passive investors, it stands at -62.90%. To see the other side of depiction, profit margin of ARIA stands at negative -35.00%; that indicates a firm actually every dollar of sales keeps in earnings. The -10.50% returns on assets presents notable condition of firm. Mostly ROA known as a comparative measure, it is best to compare it against a firm’s previous ROA numbers or the ROA of a same firm. ARIA is presenting price to cash flow of 9.42.

Opko Health, Inc. (NASDAQ:OPK) presented as an active mover, shares eased up 0.94% to traded at $10.69 in most recent trading session. The firm has floated short ratio of 20.95%, hold to candle to sentiment indicator of Short Ratio, its stand at 23.17.

Efficiency or profitability analysis gives an appropriate idea for investment decision; OPK attains returns on investment ratio of 0.70% percent, which suggests it’s viable on security that has lesser ROI. To strengthen this concept we can use profit margin, which is standing at positive 12.50% percent, and it is providing insight view about a variety of aspects of a firm’s financial performance. The operating profit margin and gross profit margin can be giving more focus view that is -1.40% percent and 52.10% percent respectively.

Turns back to returns ratios, returns on equity stands at 6.70% percent. Usually, financial analysts consider return on equity ratios in the 15-20% range as an attractive level of investment quality. Narrow down focus to firm performance, its weekly performance was -3.35% and monthly performance was 15.07%. The stock price of OPK is moving up from its 20 days moving average with 3.67% and isolated positively from 50 days moving average with 7.00%.


About Blake Escott

Blake Escott holds junior writer position in SWR. Before joining Streetwise Report, he was a freelance content Writer. He has high-level copywriting experience and particularly experienced in proofreading and editing. He covers news about different companies including all US market sectors. Interests: Commodities, Energy stocks, Sector-wise Stocks analysis, Utilities

Check Also

Stocks Skyrockets on Unusual Volume- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP), Nektar Therapeutics (NASDAQ:NKTR)

Waking on tracing line of previous stocks, Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) also making a …

Leave a Reply

Your email address will not be published. Required fields are marked *